Letter: proton pump inhibitors and risk of myocardial infarction-authors' reply

Aliment Pharmacol Ther. 2022 Jan;55(1):141-142. doi: 10.1111/apt.16684.

Michael Nolde^{1

2}, Nayeon Ahn^{1

2}, Tobias Dreischulte³, Ina-Maria Rückert-Eheberg^{1

2

4}, Florian Güntner⁵, Alexander Günter⁵, Roman Gerlach⁶, Martin Tauscher⁶, Ute Amann⁷, Jakob Linseisen^{1

2

7}, Christa Meisinger², Sebastian-Edgar Baumeister⁸

¹ Institute for Medical Information Processing, Biometry, and Epidemiology - IBE, LMU Munich, Munich, Germany.
² Department of Epidemiology, University of Augsburg, at University Hospital Augsburg, Augsburg, Germany.
³ Department of General Practice and Family Medicine, LMU Munich, Munich, Germany.
⁴ Instiute of Epidemiology, Helmholtz Zentrum München, German Research Centre for Environmental Health, Neuherberg, Germany.
⁵ Bereich Versorgungsmanagement, AOK Bayern, Munich, Germany.
⁶ Association of Statutory Health Insurance Physicians in Bavaria (Kassenärztliche Vereinigung Bayerns, KVB), Munich, Germany.
⁷ Independent Research Group Clinical Epidemiology, Helmholtz Zentrum München, German Research Centre for Environmental Health, Neuherberg, Germany.
⁸ Institute of Health Services Research in Dentistry, University of Münster, Münster, Germany.

No abstract available

Publication types